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240a Monday, February 27, 2012role of CCR5, however, is the regulation of immune-cell trafficking upon acti-
vation by its endogenous ligands: macrophage inflammatory protein 1a (MIP-
1a), MIP-1b and RANTES (Regulated on Activation, Normal T-cell Expressed
and Secreted). Since both, viral gp120 and the chemokines bind to the extracel-
lular parts of the receptor, binding of a natural ligand, e.g. RANTES, obstructs
the interaction of CCR5 with the viral protein, thereby hindering HIV infection.
This makes RANTES and other chemokines potential lead structures for novel
anti-HIV agents.
Here, we present advances on the study of the interactions of recombinantly-
expressed CCR5 with different chemokine variants and the small-molecule
inhibitor maraviroc. Experiments are performed by nuclear magnetic reso-
nance (NMR) and surface plasmon resonance (SPR), with CCR5 incorpo-
rated in either detergent micelles, lipid bilayers, or the synthetic model
membrane system of nanodiscs. Mechanistic implications of these results
are discussed.
While a 3D structure of CCR5 is still lacking, these data have the potential to
shed some new light on our understanding of HIV infection, as well as on the
topic of cellular signalling through chemokines. As the quality of preparation of
recombinant CCR5 samples improves, further milestones are expected towards
structural models of the ligand-CCR5 complexes.
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The G protein-coupled receptor (GPCR) CC chemokine receptor 5 (CCR5) is
the primary co-receptor required for HIV-1 cellular entry and the molecular
target for the HIV-1 cellular entry inhibitor maraviroc. Despite the fact that
maraviroc obtained FDA approval for therapeutic use in 2007, the precise
mode of receptor-drug interaction and its mechanism of action has not been
directly defined. Using unnatural amino acid mutagenesis and targeted photo-
crosslinking, we have identified amino acids in CCR5 that are within 3-5 A˚ of
the bound ligand. We introduced p-benzoyl-L-phenylalanine (BzF) and p-az-
ido-L-phenylalanine (AzF) at multiple specific sites in engineered CCR5 ex-
pressed in HEK-293T cells. Photocrosslinking experiments were performed
in live cells in the presence of [3H]maraviroc. Site-specific crosslinks were de-
tected by scintillation counting of Western Blot membranes of cell extracts.
The pattern of BzF and AzF crosslinks was compared based on existed models
of CCR5. This method is an extension of earlier work in which ligand ana-
logues with fluorescent tags were employed (1). Targeted photocrosslinking
using isotopically-labelled GPCR ligands allows the direct mapping of
a drug-binding site with chemical precision and can be used to discriminate
among various models of receptor-drug interaction. To our knowledge, this
is the first demonstration of a direct chemical crosslink between a GPCR
and a native small-molecule ligand. 1. Grunbeck, et al. (2011) Biochemistry
50, 3411-3413.
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Human cannabinoid CB2 receptor functions in plasma membranes of cells in
immune and hematopoietic systems upon binding of cannabinoid ligands. Pre-
viously we reported on functional reconstitution of the recombinant CB2 recep-
tor into liposomes. During solubilization and purification, structure of the
receptor in micelles is stabilized by adding anionic cholesteryl hemisuccinate
(CHS), that is used widely to maintain the functionality of recombinant
GPCR. Here we show that the functional structure of CB2 receptor in micelles
can be significantly preserved by replacing CHS with phospholipids prior to re-
constitution. By ligand binding studies on the reconstituted receptor performed
by 2H MAS NMR, that distinguishes specific binding to the receptor and non-
specific binding to the lipid matrix, and by G protein activation tests, we dem-
onstrated that the anionic 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine
(POPS) can be almost as efficient as CHS in stabilizing the receptor in micelles
while the zwitterionic PC counterpart, POPC, was much less effective. Our re-
sults obtained with various phospholipid headgroup and acyl-chain species sug-
gest that the net negative charge as well as the specific molecular structure of
the PS headgroup plays a key role in maintaining the structural integrity of the
receptor in micelles. On the reconstituted CB2 receptor in liposomes, effect of
negative electric potential of membrane surface on G protein activation was in-
vestigated by systematically changing the content of anionic CHS or PS. The
activation was highest at an anionic lipid content of about 50 mol%. Therewas no correlation between the efficiency of G protein activation and an in-
crease of hydrocarbon chain order induced by CHS or cholesterol. The results
highlight importance of anionic lipids in regulating signal transduction by CB2
receptor and possibly other class-A GPCR.
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Arrestins and heterotrimeric G proteins (Gabg) regulate G-protein-coupled re-
ceptors (GPCRs) signaling and trafficking. Arrestin binding to an activated
GPCR terminates receptor and G protein coupling, and promotes receptor inter-
nalization. The binding of the b-arrestins and G-proteins on agonist-bound
GPCRs is thought to be mutually exclusive. Here we show that b-arrestins pro-
long rather that desensitize parathyroid hormone (PTH) receptor (PTHR) sig-
naling. By using optical approaches (confocal microscopy, FRAP, TIRF,
fluorescence correlation spectroscopy, and FRET) in live cells in real time
we found that PTHR forms a ternary complex with b-arrestin1/2 and Gbg sub-
units in response to PTH stimulation. We further confirmed the formation of
a signaling PTHRarrestinGbg complex in response to PTH binding by us-
ing purified proteins in biochemical assays. Additionally, we found that the
rapid (t1/2< 60 s) assembly/disassembly dynamics formation of a receptor mi-
crodomain that contains PTH, PTHR, arrestin and Gbg subunits increases the
levels of G-protein activation and cAMP accumulation in magnitude and
duration. These data contradicted established tenets of the regulation of
GPCR signaling and raise the emerging concept that the formation of a long-
lived GPCR-Gbg-arrestin ternary complex contributes to prolonged receptor
signaling by mechanisms that presumably permit multiple rounds of GaS sub-
unit coupling and activation.
Platform: Molecular Dynamics II
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Tail-anchored (TA) proteins, which comprise approximately 5% of all trans-
membrane proteins, contain a single transmembrane domain (TMD) located
near the C-terminus. This unique organization presents a topological problem
that prevents the classical cotranslational translocation by the signal recogni-
tion particle, thus a distinct posttranslational targeting pathway is required
for membrane insertion. In yeast, this is guided entry of TA-proteins (GET)
pathway. At the center of this process is Get3, an enzyme that shuttles a TA
protein from the cytosolic Get4/Get5/Sgt2 complex to the transmembrane
Get1/Get2 site. Biochemical and structural studies have revealed that Get3 is
a homodimer that leverages the power gained through ATP binding and hydro-
lysis to undergo large-scale conformational changes between an ‘‘open’’ and
‘‘closed’’ conformation. Through the use of conventional MD simulations, en-
hanced sampling, and rigorous free energy calculations in five possible sym-
metric and non-symmetric nucleotide states, we have mapped out the
underlying potential of mean force for the protein as it progresses through
the hydrolysis cycle. Results have lead to a mechanistic model that agrees
well with experiments on the stabilities of the open and closed conformations
in the symmetric states, and were able to not only predict the existence of the
very recently discovered semi-open state, but also to closely match its structure.
In addition, calculations predict the existence of a wide-open conformation,
along with the probabilities of each of these states as nucleotides bind and un-
bind from Get3. This model improves our interpretation of experiments on
Get3, suggests important details about the GET cycle, and provides a model
system for understanding the coupling of nucleotide binding and hydrolysis
to protein conformational changes.
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Using computer simulations we investigated the effect of coexisting phases on
the properties of lipid monolayers. This is important for understanding the role
of domains in surface activity of monolayers in general, and specifically in reg-
ulation of surface tension by lung surfactant. Molecular dynamics simulations
with the coarse-grained force field MARTINI were employed to study
